|

...

CNBC

2 weeks ago

Danaher had a disappointing 2024. Its path to success next year goes through Wall Street

Danaher had a disappointing 2024. Its path to success next year goes through Wall Street

A pickup in the initial public offering market would be a boon to Danaher.

View full article

...

Latest News

Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says

1 week ago

Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise

1 week ago